IP Library Granted Patent US 7,868,138
Granted Patent B2
US 7,868,138 · App. 12/012,528 · Granted Jan 11, 2011

Methods for generating polynucleotides having desired characteristics by iterative selection and recombination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,868,138
App. No.
12/012,528
Granted
Jan 11, 2011
Kind
B2
Abstract

A method for DNA reassembly after random fragmentation, and its application to mutagenesis of nucleic acid sequences by in vitro or in vivo recombination is described. In particular, a method for the production of nucleic acid fragments or polynucleotides encoding mutant proteins is described. The present invention also relates to a method of repeated cycles of mutagenesis, shuffling and selection which allow for the directed molecular evolution in vitro or in vivo of proteins.

Claims (8)

1. A mutant green fluorescent protein (GFP) with enhanced fluorescent intensity as compared to wild type Aequorea victoria GFP, said mutant protein comprising point mutations at two or more residues corresponding to residues selected from the group consisting of F99, M153, and E172 in wild type A. victoria GFP, wherein said mutations comprise replacement of hydrophobic residues with more hydrophilic residues.

2. The mutant protein of claim 1 , wherein said mutations comprise mutations at residues corresponding to F99, M153, and E172 in wild type A. victoria GFP.

3. The mutant protein of claim 2 , wherein said mutations comprise mutation of the residue corresponding to M153 in wild type A. victoria GFP to threonine.

4. The mutant protein of claim 2 , wherein said mutations comprise mutation of the residue corresponding to E172 in wild type A. victoria GFP to glycine.

5. The mutant protein of claim 2 , wherein said mutations comprise mutation of the residue corresponding to F99 in wild type A. victoria GFP to serine;

mutation of the residue corresponding to M153 in wild type A. victoria GFP to threonine; and

mutation of the residue corresponding to E172 in wild type A. victoria GFP to glycine.

6. The mutant protein of claim 2 , wherein said mutations comprise mutation of the residue corresponding to F99 in wild type A. victoria GFP to serine.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2024
From: CODEXIS MAYFLOWER HOLDINGS, LLC
To: CODEXIS, INC.
Reel/Frame 066528/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2010
From: MAXYGEN, INC.
To: CODEXIS MAYFLOWER HOLDINGS, LLC
Reel/Frame 025550/0809 →